Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: ARMHY is accumulating their own shares--just announced
The agreement between TPL and PTSC calls for the patents to revert to the remaining party if either is bought out.  Why would they write it up that way if anyone could just buy PDS? Opty
Share
New Message
Please login to post a reply